Biotechnology
618 companies in this industry
Insider Buys (30d)
64
$37.56M
Insider Sells (30d)
462
$1.71B
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$126.50BREGNRegeneron Pharmaceuticals, Inc.
$68.29BARGXargenx SE
$45.82BALNYAlnylam Pharmaceuticals, Inc.
$43.19BRVMDRevolution Medicines, Inc.
$40.34BMRNAModerna, Inc.
$27.09BROIVRoivant Sciences Ltd.
$25.87BINSMInsmed Incorporated
$25.06BBNTXBioNTech SE
$24.56BINCYIncyte Corporation
$23.32BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | PHVS | Pharvaris N.V. | Modig Berndt | director, officer: Chief Executive Officer | Sell | 2,292 | $34.97 | $80.2K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Kaseta Michael | officer: CFO and COO | Sell | 20,430 | $71.51 | $1.46M |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Saggar Rajeev | officer: Chief Medical Officer | Sell | 9,926 | $71.51 | $709.8K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | JEFFS ROGER | director, officer: Chief Executive Officer | Sell | 35,249 | $71.51 | $2.52M |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Adair Jason | officer: Chief Business Officer | Sell | 7,863 | $71.51 | $562.3K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Krepp Sarah | officer: Chief Human Resource Officer | Sell | 7,864 | $71.51 | $562.4K |
| Jul 14, 2026 | CGON | CG Oncology Inc. | Mulay James | director | Sell | 24,165 | $75.16 | $1.82M |
| Jul 14, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 21,654 | $8.96 | $194.0K |
| Jul 14, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $535.99 | $5.09M |
| Jul 14, 2026 | BCAX | Bicara Therapeutics Inc. Common Stock | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 10,000 | $28.42 | $284.2K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Schundler Russell | officer: General Counsel | Sell | 14,738 | $71.51 | $1.05M |
| Jul 14, 2026 | CYTK | Cytokinetics, Incorporated | Blum Robert I | director, officer: President & CEO | Sell | 7,490 | $82.02 | $614.3K |
| Jul 14, 2026 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | director, officer: See Remarks | Sell | 58,333 | $12.64 | $737.4K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Boyle Dana | officer: Chief Accounting Officer | Sell | 9,002 | $71.51 | $643.7K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Khindri Sanjeev | officer: Chief Development Officer | Sell | 1,185 | $71.51 | $84.7K |
| Jul 14, 2026 | IRON | Disc Medicine, Inc. | Quisel John D | director, officer: Chief Executive Officer | Sell | 33,000 | $74.96 | $2.47M |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Moomaw Scott | officer: Chief Commercial Officer | Sell | 9,539 | $71.51 | $682.1K |
| Jul 13, 2026 | CAI | Caris Life Sciences, Inc. | HALBERT JON | director | Buy | 68,000 | $14.56 | $990.1K |
| Jul 13, 2026 | DNTH | Dianthus Therapeutics, Inc. | Savitz Ryan | officer: EVP, CFO & CBO | Sell | 31,249 | $101.03 | $3.16M |
| Jul 13, 2026 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | director | Sell | 17,167 | $84.00 | $1.44M |
| Jul 13, 2026 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10 percent owner | Buy | 91,585 | $2.42 | $222.1K |
| Jul 13, 2026 | PTCT | PTC Therapeutics, Inc. | Smith Mary L. | director | Sell | 5,834 | $90.00 | $525.1K |
| Jul 13, 2026 | ADIL | Adial Pharmaceuticals, Inc. | Coastlands Capital LP | 10 percent owner | Buy | 11,753 | $2.78 | $32.6K |
| Jul 13, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $544.60 | $5.17M |
| Jul 13, 2026 | NBIX | Neurocrine Biosciences, Inc. | Lippoldt Darin | officer: Chief Legal Officer | Sell | 10,000 | $179.60 | $1.80M |
| Jul 13, 2026 | BBIO | BridgeBio Pharma, Inc. | Cook Jennifer E. | director | Sell | 148,589 | $88.54 | $13.16M |
| Jul 13, 2026 | NBIX | Neurocrine Biosciences, Inc. | Delaet Ingrid | officer: Chief Regulatory Officer | Sell | 4,367 | $181.02 | $790.5K |
| Jul 13, 2026 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | officer: Senior Vice President, Finance | Sell | 9,699 | $84.67 | $821.3K |
| Jul 13, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 5,000 | $3.04 | $15.2K |
| Jul 13, 2026 | RCUS | Arcus Biosciences, Inc. | Jaen Juan C. | officer: President | Sell | 68,569 | $29.63 | $2.03M |
| Jul 13, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | officer: Chief Legal Officer | Sell | 30,000 | $17.96 | $538.9K |
| Jul 13, 2026 | PTCT | PTC Therapeutics, Inc. | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 2,464 | $90.25 | $222.4K |
| Jul 10, 2026 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | officer: Chief Legal Officer | Sell | 1,206 | $39.55 | $47.7K |
| Jul 10, 2026 | IMVT | Immunovant, Inc. | Gloria Melanie | officer: Chief Operating Officer | Sell | 2,036 | $39.55 | $80.5K |
| Jul 10, 2026 | PALI | Palisade Bio, Inc. | Baltera Robert Jr. | director | Buy | 45,000 | $1.97 | $88.7K |
| Jul 10, 2026 | UTHR | United Therapeutics Corporation | MALCOLM JAN | director | Sell | 325 | $550.59 | $178.9K |
| Jul 10, 2026 | SEER | Seer, Inc. | Nishar Dipchand | director | Sell | 10,660 | $2.18 | $23.3K |
| Jul 10, 2026 | BCAX | Bicara Therapeutics Inc. Common Stock | Cohlhepp Ryan | director, officer: President and COO | Sell | 28,750 | $28.98 | $833.1K |
| Jul 10, 2026 | ANTX | AN2 Therapeutics, Inc. | Eizen Joshua M | officer: See Remarks | Sell | 5,945 | $4.17 | $24.8K |
| Jul 10, 2026 | NUVL | Nuvalent, Inc. | Pelish Henry E. | officer: Chief Scientific Officer | Sell | 2,111 | $123.81 | $261.4K |
| Jul 10, 2026 | APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $133.63 | $2.67M |
| Jul 10, 2026 | CTNM | Contineum Therapeutics, Inc. | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 25 | $16.00 | $400.00 |
| Jul 10, 2026 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | officer: Chief Medical Officer | Sell | 2,171 | $30.30 | $65.8K |
| Jul 10, 2026 | INSM | Insmed Incorporated | Lewis William | director, officer: Chair and CEO | Sell | 10,699 | $117.40 | $1.26M |
| Jul 10, 2026 | IMVT | Immunovant, Inc. | Stout Jay S | officer: Chief Technology Officer | Sell | 3,487 | $39.55 | $137.9K |
| Jul 10, 2026 | TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | director, officer: President and Head of R&D | Sell | 200,000 | $6.24 | $1.25M |
| Jul 10, 2026 | BCDA | BioCardia, Inc. | Altman Peter | director, officer: President and CEO | Buy | 7,500 | $0.96 | $7.2K |
| Jul 10, 2026 | BCAX | Bicara Therapeutics Inc. Common Stock | Hyep Ivan | officer: Chief Financial Officer | Sell | 28,000 | $28.85 | $807.7K |
| Jul 9, 2026 | SER | Serina Therapeutics, Inc. | Brannan Stephen K. | director | Buy | 1,000 | $2.03 | $2.0K |
| Jul 9, 2026 | SION | Sionna Therapeutics, Inc. | Thompson Peter A. | director | Sell | 85,918 | $44.86 | $3.85M |
Showing 1–50 of 500
1 / 10
...